Trials / Recruiting
RecruitingNCT06754475
Effects of Upper Extremity Low Volume HIIT in Heart Failure
The Effect of Upper Extremity Low-Volume High-Intensity Interval Training on Physical and Cognitive Functions in Heart Failure Patients
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Tarsus University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study was planned to investigate the effects of upper extremity low-volume high-intensity interval training (LV-HIIT) on physical and cognitive function in patients with heart failure with preserved ejection fraction(HFpEF).The research was planned as a randomized controlled trial. Patients with clinically stable HFpEF at cardiology clinic will be included in the study. These cases will be randomly divided into two groups: intervention group and control grup. After 8 weeks intervention physical functions before and after treatment; functional exercise capacity, arm exercise capacities , peripheral muscle strength , fatigue cognitive functions; anxiety and depression and fear of movement will be evaluated.
Detailed description
Patients in the DV-HIIT group will receive training consisting of 4 minutes of warm-up and cool-down at 50% Wmax on an arm ergometer, 1 minute of training at 85-95% Wmax work intensity, followed by 6 interval training periods including 1 minute of active recovery periods at 50-70% Wmax, 2 days/week, totaling 8 weeks of training. The control group will be followed with standard medical treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Low-volume, high-intensity interval training | Low-volume, high-intensity interval training with an arm ergometer will be given two days a week for a total of eight weeks. |
| DRUG | Standart medical treatment | Standart medical teatment |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2026-11-01
- Completion
- 2026-12-01
- First posted
- 2024-12-31
- Last updated
- 2025-01-03
Locations
2 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06754475. Inclusion in this directory is not an endorsement.